Leukemia diagnosis: today and tomorrow

被引:24
作者
Bene, Marie C. [1 ]
Grimwade, David [2 ]
Haferlach, Claudia [3 ]
Haferlach, Torsten [3 ]
Zini, Gina [4 ]
机构
[1] Univ Hosp, Hematol Biol, Nantes, France
[2] Kings Coll London, Fac Life Sci & Med, Dept Med & Mol Genet, London, England
[3] MLL, Munich, Germany
[4] Univ Cattolica Sacro Cuore, Hematol & Clin Pathol, I-00168 Rome, Italy
基金
美国国家卫生研究院;
关键词
ACUTE MYELOID-LEUKEMIA; MINIMAL RESIDUAL DISEASE; ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; SUB-SAHARAN AFRICA; MYELODYSPLASTIC SYNDROMES; SCORING SYSTEM; EUROPEAN LEUKEMIANET; FLOW-CYTOMETRY; WORKING GROUP;
D O I
10.1111/ejh.12603
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The European LeukemiaNet (ELN) is composed of several work packages, four of them being directly involved in the various aspects of diagnosis. On the occasion of the annual ELN meeting of 2015 in Mannheim, these four work packages collectively examined the current situation and future prospects of cytomorphology, flow cytometry, cytogenetics, next-generation sequencing, and minimal residual disease detection in the context of leukemia diagnosis and follow-up. This document summarizes the outcome of this compendium.
引用
收藏
页码:365 / 373
页数:9
相关论文
共 59 条
[1]  
[Anonymous], 1986, CANCER GENET CYTOGEN, V23, P189
[2]  
[Anonymous], ASH ANN M
[3]   Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10 [J].
Bene, M. C. ;
Nebe, T. ;
Bettelheim, P. ;
Buldini, B. ;
Bumbea, H. ;
Kern, W. ;
Lacombe, F. ;
Lemez, P. ;
Marinov, I. ;
Matutes, E. ;
Maynadie, M. ;
Oelschlagel, U. ;
Orfao, A. ;
Schabath, R. ;
Solenthaler, M. ;
Tschurtschenthaler, G. ;
Vladareanu, A. M. ;
Zini, G. ;
Faure, G. C. ;
Porwit, A. .
LEUKEMIA, 2011, 25 (04) :567-574
[4]  
BENE MC, 1995, LEUKEMIA, V9, P1783
[5]   PROPOSALS FOR CLASSIFICATION OF ACUTE LEUKEMIAS [J].
BENNETT, JM ;
CATOVSKY, D ;
DANIEL, MT ;
FLANDRIN, G ;
GALTON, DAG ;
GRALNICK, HR ;
SULTAN, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1976, 33 (04) :451-&
[6]  
BERNARD A, 1984, PRESSE MED, V13, P2311
[7]   Prognostic value of monitoring a candidate immunophenotypic leukaemic stem/progenitor cell population in patients allografted for acute myeloid leukaemia [J].
Bradbury, C. ;
Houlton, A. E. ;
Akiki, S. ;
Gregg, R. ;
Rindl, M. ;
Khan, J. ;
Ward, J. ;
Khan, N. ;
Griffiths, M. ;
Nagra, S. ;
Hills, R. ;
Burnett, A. ;
Russell, N. ;
Vyas, P. ;
Grimwade, D. ;
Craddock, C. ;
Freeman, S. D. .
LEUKEMIA, 2015, 29 (04) :988-991
[8]   The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach [J].
Cornelissen, Jan J. ;
Gratwohl, Alois ;
Schlenk, Richard F. ;
Sierra, Jorge ;
Bornhaeuser, Martin ;
Juliusson, Gunnar ;
Racil, Zdenek ;
Rowe, Jacob M. ;
Russell, Nigel ;
Mohty, Mohamad ;
Lowenberg, Bob ;
Socie, Gerard ;
Niederwieser, Dietger ;
Ossenkoppele, Gert J. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (10) :579-590
[9]   Should evaluation for minimal residual disease be routine in acute myeloid leukemia? [J].
Coustan-Smith, Elaine ;
Campana, Dario .
CURRENT OPINION IN HEMATOLOGY, 2013, 20 (02) :86-92
[10]   Validation of Cell-Based Fluorescence Assays: Practice Guidelines from the International Council for Standardization of Haematology and International Clinical Cytometry Society [J].
Davis, Bruce H. ;
Dasgupta, Amar ;
Kussick, Steven ;
Han, Jin-Yeong ;
Estrellado, Annalee ;
O'Neil, Patrick ;
Hoffman, Bob ;
Purvis, Norman ;
Hunsberger, Ben ;
Vall, Horacio ;
Kaplan, David ;
Wang, Lili ;
Porwit, Anna ;
Tanqri, Shabnam ;
Shankey, T. Vincent ;
Barnett, David ;
Louzao, Raul ;
Gambell, Peter ;
De, Jitakshi ;
Oldaker, Teri ;
Hanson, Curtis ;
Wood, Brent L. ;
Jevremovic, Dragan ;
Bene, Marie C. ;
Yan, Ming ;
Jacobs, Patrick ;
Litwin, Virginia .
CYTOMETRY PART B-CLINICAL CYTOMETRY, 2013, 84 (05) :281-281